Production of Multicopy shRNA Lentiviral Vectors for Antiviral Therapy
For effective RNA interference (RNAi)-based therapies against viral infection, particularly highly mutational viruses like HCV and HIV, combinational strategies that target multiple regions within a viral genome are required to prevent resistance. The use of lentiviral vectors for combinatorial RNAi (coRNAi) offers possibilities to deliver multiple short hairpin RNA (shRNA) sequences simultaneously to individual cells while maintaining high expression levels required to suppress viral replication. By applying coRNAi, one can impart either a protective strategy, i.e., treatment prior to infection, or a long-term treatment postinfection without the eventuality of mutational outgrowth due to incomplete selection pressure. In this chapter, we provide a detailed description of the methods available to create coRNAi vectors and discuss some of the current problems and technical limitations.
- Preparation of G-Quartet Structures and Detection by Native Gel Electrophoresis
- Whole-Genome Genotyping on Bead Arrays
- Closed-Tube PCR Methods for Locus-Specific DNA Methylation Analysis
- Separation, Digestion, and Cloning of Intact Parasite Chromosomes Embedded in Agarose
- Long-PCR Amplification of Human Genomic DNA
- Delivery of Herpes Simplex Virus-Based Vectors to the Nervous System
- Avoiding False Discoveries in Association Studies
- Antitumor Vaccination with Synthetic mRNA: Strategies for In Vitro and In Vivo Preclinical Studies
- Cytoplasmic RNA Vector Derived from Nontransmissible Sendai Virus: Production and Use
- Identification of Viral Suppressors of RNAi by a Reporter Assay in Drosophila S2 Cell Culture